rhodioloside has been researched along with glucagon-like peptide 1 in 1 studies
| Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
|---|---|---|---|---|---|
| 621 | 2 | 519 | 9,484 | 1,208 | 6,374 |
| Protein | Taxonomy | rhodioloside (IC50) | glucagon-like peptide 1 (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, K; He, B; Jia, Y; Li, F; Nian, T; Wang, Z; Yan, T | 1 |
1 other study(ies) available for rhodioloside and glucagon-like peptide 1
| Article | Year |
|---|---|
Salidroside from Rhodiola wallichiana var. cholaensis reverses insulin resistance and stimulates the GLP-1 secretion by alleviating ROS-mediated activation of MAPKs signaling pathway and mitigating apoptosis.
Topics: Apoptosis; Glucagon-Like Peptide 1; Glucosides; Humans; Insulin Resistance; Mitogen-Activated Protein Kinase Kinases; Phenols; Reactive Oxygen Species; Rhodiola; Signal Transduction | 2020 |